Intrauterine therapy with cytomegalovirus hyperimmunoglobulin for a fetus congenitally infected with cytomegalovirus

Journal of Obstetrics and Gynaecology Research

Volumn 33, Issue 5, 2007, Pages 718-721

  Sato, Akira ^a   Hirano, Hideto ^b   Miura, Hiroshi ^b   Hosoya, Naoko ^b   Ogawa, Masaki ^b   Tanaka, Toshinobu ^b  

^a Akita Kumiai General Hospital   (Japan)

^b AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Congenital infection; Cytomegalovirus; Hyperimmunoglobulin; i.p. administration; Intrauterine therapy

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; IMMUNOGLOBULIN G; VIRUS ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; ASCITES; BIRTH; CASE REPORT; CELL NUCLEUS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; FETUS; FETUS HYDROPS; GESTATION PERIOD; HUMAN; HUMAN CELL; INFERIOR CAVA VEIN; INTRAUTERINE INFECTION; MALE; NEUTROPHIL; NEWBORN DEATH; NEWBORN INTENSIVE CARE; PERITONEAL CAVITY; PREGNANCY; RATING SCALE; THROMBOCYTE COUNT; UMBILICAL CORD BLOOD; UTERUS;

ADULT; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FATAL OUTCOME; FEMALE; FETAL THERAPIES; FETUS; HUMANS; HYDROPS FETALIS; IMMUNOGLOBULINS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 34548527801     PISSN: 13418076     EISSN: 14470756     Source Type: Journal    
DOI: 10.1111/j.1447-0756.2007.00637.x     Document Type: Article

References (13)

1. Stango S, Pass RF, Cloud G, Britt WJ. Primary cytomegalovirus infection in pregnancy: Incidence, transmission to the fetus and clinical outcome. JAMA 1986 256 : 1904 1908.
2. Ho-Yen DO, Joss AWL. Toxoplasma and cytomegalovirus infections in pregnancy. Curr Obstet Gynecol 1991 1 : 62 66.
3. Revello MG, Percivalle E, Baldanti F et al. Prenatal treatment of congenital human cytomegalovirus infection by fetal intravascular administration of ganciclovir. Clin Diagn Virol 1993 1 : 61 67.
4. Negishi H, Yamada H, Hirayama E et al. Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus. J Perinatol 1998 18 : 466 469.
5. Matsuda H, Kawakami Y, Furuya K et al. Intrauterine therapy for a cytomegalovirus-infected symptomatic fetus. BJOG 2004 111 : 756 757.
6. Meyers JD, Flournoy N, Thomas ED. Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 1986 153 : 478 488.
7. Blacklock HA, Griffiths P, Stirk P et al. Specific hyperimmune globulin for cytomegalovirus pneumonitis. Lancet 1985 2 : 152 153.
8. Kapoor N, Copelan EA, Tutschka PJ. Cytomegalovirus infection in bone marrow transplant recipients: Use of intravenous gamma globulin as a prophylactic and therapeutic agent. Transplant Proc 1989 21 : 3095 3096.
9. Reed KL, Appleton CP, Anderson CF et al. Doppler studies of vena cava flows in human fetuses. Insights into normal and abdominal cardiac physiology. Circulation 1990 81 : 498 505.
10. Rizzo G, Arduini D, Romanini C. Inferior vena cava velocity waveforms in appropriate- and small-for-gestational-age fetuses. Am J Obstet Gynecol 1992 166 : 1271 1280.
11. Wladimiroff JW, Huisman TWA, Stewart PA et al. Normal fetal Doppler inferior vena cava, transtricuspid, and umbilical artery flow velocity waveforms between 11 and 16 weeks' gestation. Am J Obstet Gynecol 1992 166 : 921 924.
12. Gest AL, Martin CG, Moise AA et al. Reversal of venous blood flow with atrial tachycardia and hydrops in fetal sheep. Pediatr Res 1990 28 : 233 226.
13. Kanzaki T, Chiba Y. Evaluation of the preload condition of the fetus by inferior vena cava blood flow pattern. Fetal Diagn Ther 1990 5 : 168 174.